Spanish Red Biotech Pipeline

MSD

Pembrolizumab/Enfortumab

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: Perioperative Pembrolizumab for Cis-Ineligible Muscle Invasive Bladder Cancer
Phase: 3Phase III in Spain, 2Phase II, 1Phase I